Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Arbaclofen ER (OS-440)
print preview
bookmark
share with colleague
General Information
Company
Osmotica Pharmaceutical Corp.
Description
Arbaclofen extended-release tablets
Molecular Target
Mechanism of Action
Latest Stage of Development
Phase III
Indication
Multiple sclerosis (MS)
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy
General Information